Dapxi 5mg Tablet

Dapxi 5mg Tablet contains the active ingredient dapagliflozin and belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is used to treat type 2 diabetes mellitus by helping to lower blood sugar levels.

Active Ingredient:

• Dapagliflozin: Dapagliflozin works by inhibiting the SGLT2 protein in the kidneys. This action reduces glucose reabsorption in the renal tubules, leading to increased urinary glucose excretion and lower blood sugar levels.

Uses:

Dapxi 5mg Tablet is prescribed to manage type 2 diabetes mellitus when diet and exercise alone are not sufficient to control blood sugar levels. It helps improve glycemic control by lowering blood glucose levels through its mechanism of action.

Mechanism of Action:

Dapagliflozin inhibits the SGLT2 protein in the kidneys, which reduces glucose reabsorption in the renal tubules. By increasing urinary glucose excretion, dapagliflozin helps lower blood sugar levels in patients with type 2 diabetes mellitus.

Administration:

Dapxi 5mg Tablet is taken orally, usually once daily, with or without food, as directed by a healthcare professional. The dosage may vary depending on individual patient factors and response to treatment. It is essential to follow the prescribed dosage and instructions provided by the healthcare provider.

Side Effects:

Common side effects associated with Dapxi 5mg Tablet may include:

• Genital yeast infections
• Urinary tract infections
• Increased urination
• Thirst
• Nausea
• Diarrhea
• Abdominal discomfort

Precautions:

Before using Dapxi 5mg Tablet, patients should consider the following precautions:

• Inform healthcare providers of any known allergies to dapagliflozin or other medications.
• Monitor blood sugar levels regularly, especially during the initial stages of treatment.
• Use caution in patients with renal impairment, as dapagliflozin is excreted renally.
• Inform healthcare providers of any other medications, supplements, or herbal products being taken, as they may interact with dapagliflozin.